BiotechTube
Home/Zoetis/Mike McFarland, DVM
MM

Mike McFarland, DVM

Executive Vice President and Chief Medical Officer

Zoetis

Therapeutic Areas

ParasiticidesVaccinesAnti-infectivesDermatologyPain ManagementDiagnostics

Zoetis Pipeline

DrugIndicationPhase
Librela (bedinvetmab)Canine Osteoarthritis PainLaunched
Solensia (frunevetmab)Feline Osteoarthritis PainLaunched
Vetscan OptiCellCompanion Animal Hematology DiagnosticsLaunched
mAb Pipeline CandidatesAtopic Dermatitis & Other Chronic Conditions (Dogs/Cats)Development
Next-Gen ParasiticidesParasite Prevention (Dogs/Cats)Development/Launched
Basepaws PlatformGenetic & Wellness Screening (Cats)Launched

Leadership Team at Zoetis

KP
Kristin Peck
Chief Executive Officer
WJ
Wetteny Joseph
Executive Vice President and Chief Financial Officer
RL
Roxanne Lagano
Executive Vice President and General Counsel
RP
Rob Polzer
Executive Vice President and President, U.S. Operations
View full Zoetis profile